Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Guided Therapeutics Inc

Market Cap 2.8Cr 2.44Cr 2.25Cr 2.12Cr 3.96Cr 263.85Cr 3.98Cr 27Cr 10Cr 130.03Cr 11Cr 10Cr 450.68Cr P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 3.09Cr 2.69Cr 2.48Cr 2.33Cr 4.36Cr 290.95Cr 4.39Cr 30Cr 11Cr 143.39Cr 12Cr 11Cr 496.98Cr EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 70 01/12/2016
Director/Board Member 76 10/04/2006
Chairman 67 01/10/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.63%-2.32%+18.35%-13.53% 17TCr
+1.14%-1.48%-20.16%+23.51% 14TCr
-0.33%-2.00%-8.88%-26.73% 13TCr
+0.76%-3.99%-55.32%-16.62% 6.73TCr
+0.78%+1.87%+18.09%-4.98% 5.03TCr
+0.04%-0.90%-25.23%-34.48% 4.41TCr
+2.20%-1.92%+9.99%+4.90% 3.59TCr
-0.44%-1.20%+4.74%+32.04% 3.49TCr
+0.72%-4.53%-14.33%-21.69% 2.8TCr
Average +0.61%-2.12%-8.08%-6.40% 7.81TCr
Weighted average by Cap. +0.58%-2.00%-6.62%-6.41%

Financials

2024 2025
Net sales 7T 6.1T 5.62T 5.29T 9.89T 7L 9.96T 66.89T 25.98T 3L 26.27T 25.71T 11.27L 8L 7L 6L 6L 10.84L 7.23Cr 10.92L 73.29L 28.46L 3.56Cr 28.79L 28.17L 12Cr
Net income -24.17L -21.06L -19.41L -18.26L -34.16L -23Cr -34.4L -2.31Cr -89.7L -11Cr -90.72L -88.78L -39Cr -31.96L -27.85L -25.67L -24.15L -45.17L -30Cr -45.49L -3.05Cr -1.19Cr -15Cr -1.2Cr -1.17Cr -51Cr
Net Debt 17.71L 15.43L 14.22L 13.38L 25.03L 17Cr 25.21L 1.69Cr 65.72L 8.23Cr 66.47L 65.05L 29Cr 28.76L 25.06L 23.1L 21.73L 40.65L 27Cr 40.93L 2.75Cr 1.07Cr 13Cr 1.08Cr 1.06Cr 46Cr
Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!